MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

Intuitive Surgical Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

495.8 0.17

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

486

Max

496.79

Pagrindiniai rodikliai

By Trading Economics

Pajamos

123M

688M

Pardavimai

374M

2.4B

P/E

Sektoriaus vid.

76.905

63.778

Pelnas, tenkantis vienai akcijai

2.21

Pelno marža

28.506

Darbuotojai

15,638

EBITDA

116M

810M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+29.31% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-04-22

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-30B

177B

Ankstesnė atidarymo kaina

495.63

Ankstesnė uždarymo kaina

495.8

Naujienos nuotaikos

By Acuity

36%

64%

118 / 386 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Intuitive Surgical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-01-23 21:41; UTC

Uždarbis

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

2025-01-21 18:37; UTC

Įsigijimai, susijungimai, perėmimai

Intuitive to Establish Direct Presence in Europe With Acquisition

2024-10-18 15:22; UTC

Uždarbis
Pagrindinės rinkos jėgos

Intuitive Surgical Shares Hit 52-Week High After 3Q Earnings, Revenue Beat Expectations

2024-10-17 21:33; UTC

Uždarbis
Pagrindinės rinkos jėgos

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

2024-10-17 20:56; UTC

Uždarbis

Intuitive Surgical Posts 3Q Revenue Growth

2025-01-24 21:17; UTC

Uždarbis

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

2025-01-24 18:18; UTC

Uždarbis

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

2025-01-24 13:11; UTC

Svarbiausios naujienos

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

2025-01-24 09:51; UTC

Karštos akcijos

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

2025-01-23 21:10; UTC

Uždarbis

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

2025-01-23 21:09; UTC

Uždarbis

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

2025-01-23 21:09; UTC

Uždarbis

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

2025-01-23 21:05; UTC

Uždarbis

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

2025-01-23 21:05; UTC

Uždarbis

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

2025-01-23 21:05; UTC

Uždarbis

Intuitive Surgical 4Q Rev $2.41B >ISRG

2025-01-23 21:05; UTC

Uždarbis

Intuitive Surgical 4Q Net $685.7M >ISRG

2025-01-23 21:05; UTC

Uždarbis

Intuitive Surgical 4Q EPS $1.88 >ISRG

2025-01-15 17:27; UTC

Uždarbis

Intuitive Surgical Stock Jumps. 'Da Vinci' Robots Guide the Future. -- Barrons.com

2025-01-06 12:00; UTC

Svarbiausios naujienos

Healthcare Stocks Are Down and Out. Opportunities Abound. -- Heard on the Street -- WSJ

2024-10-18 15:59; UTC

Uždarbis

Intuitive Surgical Breaks Out On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

2024-10-18 15:38; UTC

Uždarbis

Intuitive Surgical Stock Pops on Earnings Beat. What Wall Street Thinks of the Results. -- Barrons.com

2024-10-18 13:28; UTC

Uždarbis

Intuitive Surgical Eyes Breakout On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

2024-10-17 21:18; UTC

Uždarbis
Pagrindinės rinkos jėgos

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

2024-10-17 20:22; UTC

Uždarbis

Intuitive Surgical Adds To 41% Run With Massive Profit Beat, Strong Procedure Growth -- IBD

2024-10-17 20:05; UTC

Uždarbis

Intuitive Surgical 3Q Adj EPS $1.84 >ISRG

2024-10-17 20:05; UTC

Uždarbis

Intuitive Surgical 3Q Rev $2.04B >ISRG

2024-10-17 20:05; UTC

Uždarbis

Intuitive Surgical 3Q EPS $1.56 >ISRG

2024-10-17 20:05; UTC

Uždarbis

Intuitive Surgical 3Q Net $565.1M >ISRG

2024-07-19 13:50; UTC

Svarbiausios naujienos

Dow Jones, Other Indexes Open Lower As Global Outage Hits Many Companies; Netflix Climbs After Earnings -- IBD

2024-07-19 13:10; UTC

Svarbiausios naujienos

Dow Jones Futures Lower, S&P Higher As Global Outage Hits Many Companies; Netflix Climbs After Earnings -- IBD

Akcijų palyginimas

Kainos pokytis

Intuitive Surgical Inc Prognozė

Kainos tikslas

By TipRanks

29.31% į viršų

12 mėnesių prognozė

Vidutinis 641.83 USD  29.31%

Aukščiausias 711 USD

Žemiausias 570 USD

Remiantis 22 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Intuitive Surgical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

22 ratings

16

Pirkti

6

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

492.06 / 508.58Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

Weak Bullish Evidence

Rinkos nuotaikos

By Acuity

118 / 386 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.